| Obtusaquinone: a cysteine-modifying compound that targets Keap1 for degradation CE Badr, CC Da Hora, AB Kirov, E Tabet, R Amante, S Maksoud, ... ACS chemical biology 15 (6), 1445-1454, 2020 | 19 | 2020 |
| Multiplex blood reporters for simultaneous monitoring of cellular processes MSS Bovenberg, MH Degeling, S Hejazi, RJ Amante, M van Keulen, ... Analytical chemistry 85 (21), 10205-10210, 2013 | 19 | 2013 |
| Anticipating mechanisms of resistance to PI3K inhibition in breast cancer: a challenge in the era of precision medicine C Leroy, RJ Amante, M Bentires-Alj Biochemical Society Transactions 42 (4), 733-741, 2014 | 14 | 2014 |
| Protein Tyrosine Phosphatase SHP2 Controls Interleukin-8 Expression in Breast Cancer Cells RJ Amante, P Auf der Maur, V Richina, A Sethi, V Iesmantavicius, ... Journal of Mammary Gland Biology and Neoplasia 27 (2), 145-153, 2022 | 3 | 2022 |
| PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer RJ Amante, C Jehanno, D De Silva, MM Coissieux, M Ackerknecht, ... Journal of mammary gland biology and neoplasia 28 (1), 13, 2023 | 2 | 2023 |
| Cell-based bioluminescence screening assays RJ Amante, CE Badr Bioluminescent Imaging: Methods and Protocols, 185-195, 2014 | 2 | 2014 |
| SHP2 blockade sensitizes triple negative breast cancers to PI3K inhibition leading to metastatic shrinkage R Amante University_of_Basel, 2019 | | 2019 |
| The ninth ENBDC Weggis meeting: growth and in-depth characterisation of normal and neoplastic breast cells KE Wiese, RJ Amante, MM Vivanco, M Bentires-Alj, RD Iggo Breast Cancer Research 19, 1-4, 2017 | | 2017 |
| An RNAi Screening Platform To Identify Modulators of Glioma Stem Cells Viability and Differentiation CE Badr, R Amante, S Van Hoppe, BA Tannous MOLECULAR THERAPY 21, S176-S176, 2013 | | 2013 |
| GlaxoSmithKline Award Lecture MAM Reijns, AP Jackson, C Wellbrock, C Leroy, RJ Amante, ... | | |
Tannous BAMassachusetts General Hospital and Harvard Medical SchoolVerified email at hms.harvard.edu
